A different perspective to approaching cancer symptoms in children

Abstract

A sound and comprehensive knowledge base about symptoms in children experiencing cancer is necessary if health care professionals hope to effectively manage their symptoms. To date, there is still much to be discovered about how children with cancer and their families experience childhood cancer symptoms. Accordingly, a longitudinal qualitative study was undertaken between July 1998 and December 2000 to explore and describe the childhood cancer symptom course from the perspectives of children and their families. The study was conducted in three settings: the participants' homes and both an inpatient and outpatient pediatric cancer unit located in Western Canada. Thirty-nine children (4 1/2- to 18-year-old males and females) with mixed cancer diagnoses and their families (parents and siblings) participated in the study. The majority of the children were diagnosed with either leukemia or lymphoma (72%), had siblings (87%), and two parents (87.2%), and remained in remission at the completion of the study (90%). All the children received chemotherapy either alone (56%) or in combination with surgery (18%), radiation (5%), radiation and bone marrow transplant (8%), radiation and surgery (10%), and surgery, radiation, and bone marrow transplant (3%). Multiple methods of data collection were used including open-ended formal interviewing and participant observation. Interview and participant observation data were analyzed by the constant comparative method of data analysis. The creation of illness narratives added to the understanding of children's and families' experiences. In addition to providing a description of how the symptoms affected children's and families' daily living, findings related to how to health professionals can better understand and approach children's cancer symptoms emerged. When families, physicians, nurses, and other health professionals approached children's symptoms solely as side effects (e.g., nausea) or singular physical and psychological states, children provided minimal description of what they were actually experiencing. However, a greater understanding was achieved when the symptoms were approached as dynamic multidimensional experiences that occurred within a particular context. Children experienced symptoms as feeling states. Critical to children's feeling states were the meanings that children and their families assigned to the symptoms. Viewing cancer symptoms in the context of assigned meanings has implications for how symptoms are assessed and managed. The need to develop a children's symptom assessment tool based on assigned meanings is recommended.

Why do young people with CFS/ME feel anxious? A qualitative study

“…Suris, Parera, & Puig, 1996;Woodgate, 1998;Woodgate, Degner, & Yanofsky, 2003). Indeed, an increase in emotionality was described by the young people in this study (theme 3).…”

Children and Adolescents with Cancer: experiences with Chemotherapy

“…The physical and mental exhaustion, fear and unrest that the process caused in the children, the adolescents and the families, reinforces the uncertainties of life faced with cancer, making it more painful (12) .…”

“…As much as treatment changes the daily activities of the child and adolescent, the family should seek to maintain the routine prior to diagnosis, so that the sick child will not feel incapacitated, powerless and dependent (2) , since the symptoms bring to the children the feeling that the cancer is "more real" in their lives and leads to changes in family routines, including losses and restrictions (12,15) .…”

Health status and QOL instruments used in childhood cancer research: deciphering conceptual content using World Health Organization definitions

“…Qualitative methods are often recommended to explore a depth of understanding about children's personal perspectives and how health conditions can impact upon individual lives [5,41]. However, quantitative instruments are tools that can assess the QOL of many children so that conclusions about the effectiveness of cancer therapies or treatments can be made.…”